Last reviewed · How we verify
NCT03281564: ABLIMCO
Quality of Life After Laparoscopic Removal of Essure®
trial testing Quality of life after Essure® removal in Contraceptive Device; Complications in 474 participants. Completed in 17 October 2023.
17 October 2023
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 474 |
| Start date | 14 October 2017 |
| Primary completion | 17 October 2023 |
| Estimated completion | 17 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Quality of life after Essure® removal
Conditions studied
- Contraceptive Device; Complications — all drugs for Contraceptive Device; Complications →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
18 and older, female only, with Contraceptive Device; Complications or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life. This prospectice study aim to assess the quality of life 1, 3, 6 and 12 months after Essure® removal.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Quality of life after laparoscopic removal of Essure<sup>®</sup> sterilization devices.
Chene G, Cerruto E, Moret S, Lebail-Carval K, et al · · 2019 · cited 10× · PMID 31404292 · DOI 10.1016/j.eurox.2019.100054 -
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure<sup>®</sup> implant removal: a cross-sectional study.
Trecourt A, Devouassoux-Shisheboran M, Nohuz E, Cerruto E, et al · · 2023 · cited 2× · PMID 37365993 · DOI 10.1080/13625187.2023.2218953
Verify or expand the search:
- PubMed search for NCT03281564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraceptive Device; Complications
Currently open trials in the same condition.
- NCT06355713 — Improvement of Symptoms After Removal of the Essure® Contraceptive Implant · NA · recruiting
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03281564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 13 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03281564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing